These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3785485)

  • 1. Relationship between aldosterone and sodium, potassium, and uric acid clearance in cirrhosis with and without ascites.
    Decaux G; Hanson B; Cauchie P; Bosson D; Unger J
    Nephron; 1986; 44(3):226-9. PubMed ID: 3785485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood.
    Nguyen-Khac E; Thevenot T; Capron D; Dharancy S; Paupart T; Thabut D; Tiry C
    Eur J Intern Med; 2008 Dec; 19(8):613-8. PubMed ID: 19046728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis.
    Simón MA; Díez J; Prieto J
    Gastroenterology; 1991 Nov; 101(5):1354-60. PubMed ID: 1936807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raised urea clearance in cirrhotic patients with high uric acid clearance is related to low salt excretion.
    Decaux G; Prospert F; Namias B; Schlesser M; Soupart A
    Gut; 1992 Aug; 33(8):1105-8. PubMed ID: 1398236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amiloride on renal lithium handling in nonazotemic ascitic cirrhotic patients with avid sodium retention.
    Angeli P; De Bei E; Dalla Pria M; Caregaro L; Ceolotto G; Albino G; Gatta A
    Hepatology; 1992 Apr; 15(4):651-4. PubMed ID: 1551643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of renin and aldosterone in cirrhotic patients with ascites.
    Rosoff L; Zia P; Reynolds T; Horton R
    Gastroenterology; 1975 Sep; 69(3):698-705. PubMed ID: 1158087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal distal tubular handling of sodium in central fluid volume homoeostasis in preascitic cirrhosis.
    Sansoè G; Ferrari A; Baraldi E; Castellana CN; De Santis MC; Manenti F
    Gut; 1999 Nov; 45(5):750-5. PubMed ID: 10517915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
    Sellars L; Shore AC; Mott V; Wilkinson R
    Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance.
    Angeli P; Gatta A; Caregaro L; Menon F; Sacerdoti D; Merkel C; Rondana M; de Toni R; Ruol A
    Eur J Clin Invest; 1990 Feb; 20(1):111-7. PubMed ID: 2108033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic and aquaretic effects of intravenously infused calcium in preascitic human cirrhosis: physiopathological and clinical implications.
    Sansoè G; Wong F
    Gut; 2007 Aug; 56(8):1117-23. PubMed ID: 17303596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of a dynamic aldosterone-independent distal tubular control of renal sodium excretion in compensated liver cirrhosis.
    Sansoè G; Silvano S; Rosina F; Smedile A; Rizzetto M
    J Intern Med; 2005 Apr; 257(4):358-66. PubMed ID: 15788006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration].
    Ando M
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association of Urinary Sodium and Potassium with Renal Uric Acid Excretion in Patients with Chronic Kidney Disease.
    Li F; Guo H; Zou J; Chen W; Lu Y; Zhang X; Fu C; Xiao J; Ye Z
    Kidney Blood Press Res; 2018; 43(4):1310-1321. PubMed ID: 30099444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
    Decaux G
    J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood volume and urinary sodium, potassium and uric acid in cirrhosis. Evidence of the hypersensitivity of the nephron to aldosterone].
    Decaux G; Hanson B; Cauchie P; Bosson D; Unger J
    Acta Gastroenterol Belg; 1986; 49(1):13-9. PubMed ID: 3766056
    [No Abstract]   [Full Text] [Related]  

  • 16. Naloxone increases water and electrolyte excretion after water loading in patients with cirrhosis and ascites.
    Leehey DJ; Gollapudi P; Deakin A; Reid RW
    J Lab Clin Med; 1991 Nov; 118(5):484-91. PubMed ID: 1940589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Directional velocity of the arterial flow, systemic vascular resistance and urinary excretion of sodium in cirrhotic patients].
    Aliaga L; Mediavilla JD; Omar M; Zozaya JM; Prieto J
    Presse Med; 1995 Apr; 24(16):758-62. PubMed ID: 7784414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High uric acid and urea clearance in cirrhosis secondary to increased "effective vascular volume".
    Decaux G; Dumont I; Naeije N; Mols P; Melot C; Mockel J
    Am J Med; 1982 Sep; 73(3):328-34. PubMed ID: 7124759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
    Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
    Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid levels in patients with cirrhosis: a reevaluation.
    Lee WC; Lin HC; Hou MC; Lin HY; Lee FY; Wang SS; Chang FY; Lee SD
    J Clin Gastroenterol; 1999 Oct; 29(3):261-5. PubMed ID: 10509953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.